June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountfenin.es
Global Rank
#6,657,596
271,670Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
56.91%
Pages per Visit
1.57
Avg Visit Duration
00:00:53
- Company
- - -
- Industry
- - -
Top 10 fenin.es Competitors
The Top 10 Sites Like fenin.es in June 2026 are ranked by their affinity to fenin.es in terms of keyword traffic, audience targeting, and market overlap
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
90.16%
Pages per Visit
1.10
Avg Visit Duration
- -
Similarity Score
100%REVISTA DE LA ASOCIACIÓN ESPAÑOLA DE MEDICAMENTOS GENÉRICOS
- Company
- - -
- Industry
- - -
Global Rank
#4,292,536
25,102Bounce Rate
41.86%
Pages per Visit
1.83
Avg Visit Duration
00:00:25
Similarity Score
94%footcare at natural therapies provides podiatry and chiropody services in edinburgh and linlithgow.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
86%María Martín, consejera de Salud de La Rioja, habla en ConSalud TV sobre la falta de profesionales sanitarios y analiza los retos de sanidad.
- Company
- - -
- Industry
- - -
Bounce Rate
53.59%
Pages per Visit
2.28
Avg Visit Duration
00:00:28
Similarity Score
66%fenin.es's top 5 competitors in June 2026 are: hubc.ub.edu, aeseg.es, e-therapies.co.uk, consalud.es, and more.
According to Similarweb data of monthly visits, fenin.es’s top competitor in June 2026 is hubc.ub.edu. fenin.es 2nd most similar site is aeseg.es, and closing off the top 3 is e-therapies.co.uk.
consalud.es ranks as the 4th most similar website to fenin.es and ranks fifth in June 2026.
The other five competitors in the top 10 list are , , , , and .